GSK plc — RNS

Regulatory news across GSK, GSK

Date	TIDM	Time	Date	TIDM	TitleTitle (filtered)	Company	Source
10/09/26	GSK	15:30:00	10 Sept 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
10/09/26	GSK	07:00:05	10 Sept 2026	Japan approval of Shingrix in a prefilled syringe	GSK	Japan approval of Shingrix in a prefilled syringe	GSK PLC	RNS
09/09/26	GSK	15:30:01	9 Sept 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
09/09/26	GSK	15:30:01	9 Sept 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
01/09/26	GSK	15:00:00	1 Sept 2026	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
01/09/26	GSK	07:00:14	1 Sept 2026	mRNA flu vaccine candidate to advance to phase III	GSK	mRNA flu vaccine candidate to advance to phase III	GSK PLC	RNS
26/08/26	GSK	15:30:00	26 Aug 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
24/08/26	GSK	15:30:00	24 Aug 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
24/08/26	GSK	07:02:01	24 Aug 2026	First global approval for Hibsago in Japan	GSK	First global approval for Hibsago in Japan	GSK PLC	RNS
24/08/26	GSK	07:00:09	24 Aug 2026	US FDA to review Jemperli for rectal cancer	GSK	US FDA to review Jemperli for rectal cancer	GSK PLC	RNS
13/08/26	GSK	15:33:39	13 Aug 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
11/08/26	GSK	15:30:00	11 Aug 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
03/08/26	GSK	15:00:00	3 Aug 2026	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
30/07/26	GSK	15:30:00	30 Jul 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
28/07/26	GSK	12:05:01	28 Jul 2026	New GSK flagship R&D centre in Cambridge	GSK	New GSK flagship R&D centre in Cambridge	GSK PLC	RNS
28/07/26	GSK	12:00:00	28 Jul 2026	2nd Quarter Results	GSK	2nd Quarter Results	GSK PLC	RNS
28/07/26	GSK	11:06:50	28 Jul 2026	Hansoh positive 2nd Phase III results for Riz-Rez	GSK	Hansoh positive 2nd Phase III results for Riz-Rez	GSK PLC	RNS
24/07/26	GSK	15:30:00	24 Jul 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
24/07/26	GSK	15:00:00	24 Jul 2026	Admission to Trading	GSK	Admission to Trading	GSK PLC	RNS
22/07/26	GSK	17:22:55	22 Jul 2026	Jideytro approved in US for certain lung cancers	GSK	Jideytro approved in US for certain lung cancers	GSK PLC	RNS
20/07/26	GSK	07:00:07	20 Jul 2026	Bexsero 1-dose booster EMA file acceptance	GSK	Bexsero 1-dose booster EMA file acceptance	GSK PLC	RNS
17/07/26	GSK	12:00:01	17 Jul 2026	Audit tender conclusion	GSK	Audit tender conclusion	GSK PLC	RNS
17/07/26	GSK	09:30:00	17 Jul 2026	Camlipixant phase III results update	GSK	Camlipixant phase III results update	GSK PLC	RNS
16/07/26	GSK	15:30:00	16 Jul 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
15/07/26	GSK	13:38:08	15 Jul 2026	GSK completes acquisition of Nuvalent, Inc	GSK	GSK completes acquisition of Nuvalent, Inc	GSK PLC	RNS
14/07/26	GSK	15:30:01	14 Jul 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
13/07/26	GSK	15:30:00	13 Jul 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
13/07/26	GSK	07:00:10	13 Jul 2026	Positive Jemperli data in dMMR/MSI-H rectal cancer	GSK	Positive Jemperli data in dMMR/MSI-H rectal cancer	GSK PLC	RNS
10/07/26	GSK	11:58:58	10 Jul 2026	Hansoh positive Phase III results for Riz-Rez	GSK	Hansoh positive Phase III results for Riz-Rez	GSK PLC	RNS
09/07/26	GSK	15:30:00	9 Jul 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
09/07/26	GSK	10:00:00	9 Jul 2026	Directorate change	GSK	Directorate change	GSK PLC	RNS
01/07/26	GSK	15:00:01	1 Jul 2026	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
29/06/26	GSK	15:00:00	29 Jun 2026	Holding(s) in Company	GSK	Holding(s) in Company	GSK PLC	RNS
29/06/26	GSK	15:00:00	29 Jun 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
26/06/26	GSK	15:00:01	26 Jun 2026	Holding(s) in Company	GSK	Holding(s) in Company	GSK PLC	RNS
24/06/26	GSK	15:30:01	24 Jun 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
24/06/26	GSK	14:52:05	24 Jun 2026	GSK announces tender offer to acquire Nuvalent	GSK	GSK announces tender offer to acquire Nuvalent	GSK PLC	RNS
23/06/26	GSK	15:30:01	23 Jun 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
22/06/26	GSK	15:00:01	22 Jun 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
17/06/26	GSK	16:06:03	17 Jun 2026	cUTI oral antibiotic Tebipenem approved by US FDA	GSK	cUTI oral antibiotic Tebipenem approved by US FDA	GSK PLC	RNS
15/06/26	GSK	15:00:00	15 Jun 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
12/06/26	GSK	07:00:06	12 Jun 2026	Momelotinib orphan drug designations for VEXAS	GSK	Momelotinib orphan drug designations for VEXAS	GSK PLC	RNS
11/06/26	GSK	15:30:01	11 Jun 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
10/06/26	GSK	15:30:00	10 Jun 2026	Director/PDMR Shareholding	GSK	Director/PDMR Shareholding	GSK PLC	RNS
09/06/26	GSK	17:51:15	9 Jun 2026	Dr Hal Barron – New Directorship	GSK	Dr Hal Barron – New Directorship	GSK PLC	RNS
09/06/26	GSK	07:00:01	9 Jun 2026	GSK enters agreement to acquire Nuvalent, Inc.	GSK	GSK enters agreement to acquire Nuvalent, Inc.	GSK PLC	RNS
08/06/26	GSK	15:00:00	8 Jun 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
01/06/26	GSK	15:00:00	1 Jun 2026	Total Voting Rights	GSK	Total Voting Rights	GSK PLC	RNS
01/06/26	GSK	15:00:00	1 Jun 2026	Transaction in Own Shares	GSK	Transaction in Own Shares	GSK PLC	RNS
28/05/26	GSK	09:30:00	28 May 2026	Positive Phase 3 data for bepirovirsen	GSK	Positive Phase 3 data for bepirovirsen	GSK PLC	RNS

Showing 1–50 of 2,809 announcements